Neurobiological Technologies, Inc. (NTII)
0.0000
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Neurobiological Technologies Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | -0.208 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | -0.0184 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| September 30, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| September 30, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| September 30, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| March 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| September 30, 2002 | 0.00 |
| June 30, 2002 | 0.00 |
| March 31, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| September 30, 2001 | 0.00 |
| June 30, 2001 | 0.00 |
| March 31, 2001 | 0.00 |
| December 31, 2000 | 0.00 |
| September 30, 2000 | 0.00 |
| June 30, 2000 | 0.00 |
| March 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| September 30, 1999 | -0.774 |
| June 30, 1999 | -0.0975 |
| March 31, 1999 | -1.150 |
| December 31, 1998 | 0.00 |
| September 30, 1998 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.376 |
| Amgen, Inc. | 6.238 |
| Altimmune, Inc. | 0.1262 |
| Amarantus Bioscience Holdings, Inc. | -- |
| Aligos Therapeutics, Inc. | 0.1369 |